Search For "phase 3 trial"
Lilly's orforglipron consistent with injectable GLP-1 medicines in Phase 3
Updated : 1 year, 1 month ago IST
According to an official statement from Eli Lilly and Company, "Orforglipron is the first oral small-molecule glucagon-like peptide-1 (GLP-1) receptor agonist, taken without food and water restrictions, to successfully complete a Phase 3 trial."
Read More
Rakuten Medical to start a Global Phase 3 Trial of Alluminox Treatment usi
Updated : 3 years ago IST
Mumbai (Maharashtra) [India], May 23 (ANI/BusinessWire India): Rakuten Medical, Inc. (Rakuten Medical), a global biotechnology company developing and commercializing precision, cell-targeting therapies based on its proprietary Alluminox™ platform, today announced that the Company has b
Read More
Bharat Biotech gets SEC approval for phase 3 clinical trials of COVID boos
Updated : 4 years, 4 months ago IST
New Delhi [India], January 5 (ANI): The Subject Experts Committee (SEC) of the Drug Controller General of India (DCGI) on Wednesday granted approval to Bharat Biotech for conducting intranasal phase 3 trials and heterologous trials for COVID-19 booster intranasal vaccine for those who hav
Read More
Sputnik Light Covid vaccine gets permission for Phase 3 trials in India
Updated : 4 years, 8 months ago IST
New Delhi [India], September 15 (ANI): The Drug Controller General of India has given its approval to the single-dose COVID-19 vaccine version of the Sputnik V vaccine 'Sputnik Light' to conduct trials on the Indian population to check whether the vaccine gives a similar immune response i
Read More
Will take another 4-5 months to publish phase 3 trials data of ZyCoV-D vac
Updated : 4 years, 9 months ago IST
New Delhi [India], August 21 (ANI): Managing Director of Zydus Group Dr Sharvil Patel on Saturday said that his firm will soon apply for the Indian drug regulator's approval to conduct trials of ZyCoV-D on children above 2 years and added that it will take another 4-5 months to publish the p
Read More
Sanofi, GSK receive approval for Phase 3 trial of COVID vaccine in India
Updated : 4 years, 10 months ago IST
New Delhi [India], July 8 (ANI): French pharmaceutical company Sanofi and its British partner GSK (GlaxoSmithKline plc) received approval for their Phase 3 clinical study in India, to assess the safety, efficacy and immunogenicity of their adjuvanted recombinant-protein COVID-19 vaccine cand
Read More
After release of Covaxin's phase 3 efficacy data, NTAGI chief says it will
Updated : 4 years, 11 months ago IST
New Delhi [India], (ANI): Hours after Bharat Biotech announced that its vaccine Covaxin's efficacy against COVID-19 is 77.8 per cent, National Technical Advisory Group on Immunisation (NTAGI) Chief Dr NK Arora said that these results will help the vaccine get recognition from the World Healt
Read More
Bharat Biotech releases Phase 3 trial results of Covaxin, claims vaccine e
Updated : 4 years, 11 months ago IST
Hyderabad (Telangana) [India], July 3 (ANI): Hyderabad-based Bharat Biotech on Saturday concluded a final analysis for its vaccine Covaxin efficacy from phase-3 clinical trial claiming it to be 77.8 per cent effective against COVID-19.
Read More
Don't need Phase 3 trials, Sputnik Light vaccine can submit Russian safety
Updated : 4 years, 11 months ago IST
New Delhi [India], July 1 (ANI): Sputnik vaccine's India-partner Dr Reddy's on Thursday informed that the government panel has told the pharma firm that it does not need to conduct Phase 3 trials for Sputnik Light and only require to submit Russian safety data for approval in India.
Read More
Dr Reddy's denied approval for Phase 3 trials of Sputnik Light Covid-19 va
Updated : 4 years, 11 months ago IST
New Delhi [India], July 1 (ANI): The central government's Subject Expert Committee (SEC) has denied permission to Dr Reddy's Laboratories for conducting Phase 3 trials of Russia's COVID-19 vaccine Sputnik Light in India.
Read More
DCGI likely to approve phase 3 trial data of Covaxin on Tuesday
Updated : 4 years, 11 months ago IST
New Delhi [India], June 22 (ANI): The Drugs Controller General of India (DCGI) is likely to approve Phase III trial data of Covaxin on Tuesday, sources said.
Read More
Novavax's vaccine, also produced by SII, found 90 pc effective against COV
Updated : 4 years, 11 months ago IST
New Delhi [India], June 14 (ANI): US Biotechnology company Novavax on Monday announced that its Covid-19 vaccine provides 100 per cent protection against moderate and severe symptoms of the disease and 90.4 per cent efficacy overall in phase 3 trials.
Read More